Rifamycin Drug-Drug Interactions: A Guide for Primary Care Providers Treating Latent Tuberculosis Infection

Rifamycin Drug-Drug Interactions: A Guide for Primary Care Providers Treating Latent Tuberculosis Infection was created through a collaboration of the State of California Department of Public Health, Tuberculosis Control Branch (CDPH), the Rutgers Ernest Mario School of Pharmacy (EMSOP), the Rutgers Global Tuberculosis Institute (GTBI), and the Curry International Tuberculosis Center (CITC).

This guide was created to clarify drug interactions between rifamycins and drugs commonly used in primary care.

Date of Release: December 2022